{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:51:33Z","timestamp":1791215493846,"version":"4.1.0"},"reference-count":8,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"DOI":"10.1001\/jamainternmed.2026.4891","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:00:45Z","timestamp":1791212445000},"source":"Crossref","is-referenced-by-count":0,"title":["Not All Immunosuppressive Agents Need to Be Interrupted During COVID-19 Vaccination"],"prefix":"10.1001","author":[{"given":"Jin Kyun","family":"Park","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Bong","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea"},{"name":"Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"issue":"3","key":"iic260035r1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/art.42386","article-title":"2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases.","volume":"75","author":"Bass","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"iic260035r2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments.","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"iic260035r3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41584-024-01107-7","article-title":"Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis.","volume":"20","author":"Chang","year":"2024","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"iic260035r4","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1136\/annrheumdis-2018-213222","article-title":"Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.","volume":"77","author":"Park","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"iic260035r5","article-title":"Temporary cessation of DMARD therapy and COVID-19 supplemental dose vaccine immunogenicity in patients with inflammatory arthritis: the COVER randomized clinical trial.","author":"Curtis","journal-title":"JAMA Intern Med"},{"issue":"5","key":"iic260035r6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.ard.2026.01.002","article-title":"Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial.","volume":"85","author":"Hawkins","year":"2026","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"iic260035r7","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/art.42372","article-title":"American College of Rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 5.","volume":"75","author":"Curtis","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"iic260035r8","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1016\/S2665-9913(24)00084-5","article-title":"Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial.","volume":"6","author":"Park","year":"2024","journal-title":"Lancet Rheumatol"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2854547\/jamainternal_park_2026_ic_260035_1789768869.9083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:00:46Z","timestamp":1791212446000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2854547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":8,"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2026.4891","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,5]]}}}